The market expects Editas Medicine (EDIT) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended March 2024. This widely-known consensus ...

A month has gone by since the last earnings report for Editas Medicine (EDIT). Shares have lost about 4.3% in that time frame, underperforming the S&P 500. Will the recent negative trend continue ...